Correlation Between NioCorp Developments and Microbot Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NioCorp Developments and Microbot Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NioCorp Developments and Microbot Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NioCorp Developments Ltd and Microbot Medical, you can compare the effects of market volatilities on NioCorp Developments and Microbot Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NioCorp Developments with a short position of Microbot Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of NioCorp Developments and Microbot Medical.

Diversification Opportunities for NioCorp Developments and Microbot Medical

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between NioCorp and Microbot is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding NioCorp Developments Ltd and Microbot Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Microbot Medical and NioCorp Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NioCorp Developments Ltd are associated (or correlated) with Microbot Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Microbot Medical has no effect on the direction of NioCorp Developments i.e., NioCorp Developments and Microbot Medical go up and down completely randomly.

Pair Corralation between NioCorp Developments and Microbot Medical

Allowing for the 90-day total investment horizon NioCorp Developments Ltd is expected to under-perform the Microbot Medical. But the stock apears to be less risky and, when comparing its historical volatility, NioCorp Developments Ltd is 1.16 times less risky than Microbot Medical. The stock trades about -0.05 of its potential returns per unit of risk. The Microbot Medical is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  266.00  in Microbot Medical on August 31, 2024 and sell it today you would lose (169.00) from holding Microbot Medical or give up 63.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NioCorp Developments Ltd  vs.  Microbot Medical

 Performance 
       Timeline  
NioCorp Developments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days NioCorp Developments Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental drivers remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Microbot Medical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.

NioCorp Developments and Microbot Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NioCorp Developments and Microbot Medical

The main advantage of trading using opposite NioCorp Developments and Microbot Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NioCorp Developments position performs unexpectedly, Microbot Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbot Medical will offset losses from the drop in Microbot Medical's long position.
The idea behind NioCorp Developments Ltd and Microbot Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume